ADA-308 (Aranda Pharma)

N/A

Report date: 2023/08/30 16:48:51
NME

Base Information

Drug NameADA-308 (Aranda Pharma)
Drug Alias NameADA-308ADA308
ClassificationSmall molecules
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsAlopeciaAcne VulgarisProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAranda Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAranda Pharma Ltd
Inactive CompaniesN/A
Active IndicationsAlopeciaAcne Vulgaris
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A